Blood Flow Restriction & Tennis Elbow Rehab

Last updated: April 22, 2025
Sponsor: Julie Nuelle
Overall Status: Active - Recruiting

Phase

N/A

Condition

Tennis Elbow

Treatment

Blood Flow Restriction Device

Standard Physical Therapy

Clinical Study ID

NCT05237869
2070985
  • Ages 18-65
  • All Genders

Study Summary

Lateral epicondylitis (LE), often referred to as "tennis elbow" is a common and debilitating overuse injury affecting 1-3% of adults annually. LE is most often defined as a syndrome of pain near the area of the lateral epicondyle of the elbow commonly effecting the origin of the extensor carpi radialis brevis with associated weakness; it most commonly effects the dominant arm. The best treatment for LE is unknown and research to support current treatment methods are insufficient. A common limitation in functional recovery experienced by this population is pain at the lateral aspect of the elbow. As such, innovative therapeutic interventions directed at quickly reducing pain may address this unmet need and allow for improved outcomes, as well as earlier return to function.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Ages 18-65 years of age

  2. Diagnosis of lateral epicondylitis confirmed by the treating orthopaedic surgeon andultrasound

  3. Must be able to read and write in English

  4. Able to provide own written consent

Exclusion

Exclusion Criteria:

  1. Patients over 65 years of age

  2. Contralateral upper extremity involvement resulting in less than normal range ofmotion, muscle strength or daily pain greater than 1/10

  3. History of prior injection for treatment of lateral epicondylitis

  4. Pregnancy

  5. Recent history of deep venous thrombosis (within the past 12 months)

  6. Active treatment with anticoagulants

  7. History of upper quadrant lymph node dissection

  8. History of endothelial dysfunction

  9. Patient history of easy bruising

  10. Active infection in the injured arm

  11. Cancer

  12. Uncontrolled peripheral vascular disease

  13. Uncontrolled diabetes mellitus

Study Design

Total Participants: 250
Treatment Group(s): 2
Primary Treatment: Blood Flow Restriction Device
Phase:
Study Start date:
May 20, 2022
Estimated Completion Date:
April 01, 2026

Connect with a study center

  • University of Missouri Health System

    Columbia, Missouri 65212
    United States

    Active - Recruiting

  • Vicki Jones

    Columbia, Missouri 65212
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.